Consider extended postop thromboprophylaxis when VTE risk reaches 0.88%June 10, 2013HematologyCardiology
Aspirin better than heparin at VTE prevention after total hip arthroplastyJune 3, 2013CardiologyRheumatologyHematology
FDA approves PCC to reverse warfarin-induced acute bleedingApril 30, 2013CardiologyWomen's HealthHematology
All glucocorticoids linked to increased risk of VTEApril 1, 2013DiabetesRheumatologyPulmonologyHematologyCardiologyPainNeurology
Beriplex outperforms plasma for rapid warfarin reversalDecember 13, 2012HematologyPulmonologyOncology
